Skip to content Skip to footer
Filgrastim-Aafi: Benefits, Reviews, Info, Side Effects!
Rx Details
Filgrastim-Aafi
Zarxio, Nivestym, Granix
Filgrastim-Aafi
Prescription
Drug
Drugs
Biological Product
stimulates white blood cell production, reduces risk of infection, supports recovery from chemotherapy, aids in bone marrow transplant recovery, treats neutropenia
Bone Pain, Cough, Decreased Appetite, Diarrhea, Dizziness, Fatigue, Fever, Headache, Injection Site Reactions, Joint Pain, Muscle Pain, Nausea, Nosebleeds, Rash, Shortness Of Breath, Vomiting
Filgrastim, marketed under various brand names including Filgrastim-Aafi, is a medication used to stimulate the production of white blood cells. The average dosage of Filgrastim can vary depending on the specific condition being treated, the patient’s weight, and the prescribing doctor’s recommendations. For adults undergoing chemotherapy, a common dosage is 5 micrograms per kilogram of body weight per day, administered as a subcutaneous injection. The treatment typically starts 24 to 72 hours after chemotherapy and continues until the patient’s white blood cell count returns to a safe level. It’s important to follow the specific dosage instructions provided by a healthcare professional, as individual needs can vary. Always consult with a doctor or pharmacist for guidance tailored to your specific situation.
Neutropenia, chemotherapy-induced neutropenia, bone marrow transplantation, severe chronic neutropenia
Generally well-tolerated with mild side effects.
No Interactions Reported
$200 – $500
$1,000

A Synopsis of

Filgrastim-Aafi

Filgrastim-Aafi is a medication that belongs to a class of drugs known as colony-stimulating factors. It is used to help stimulate the production of white blood cells in patients who are undergoing certain types of cancer treatment, such as chemotherapy. White blood cells are an essential part of the immune system, helping to fight off infections and keep the body healthy.

This medication is administered through injection and works by stimulating the bone marrow to produce more white blood cells. By increasing the number of white blood cells in the body, Filgrastim-Aafi can help reduce the risk of infection in patients undergoing cancer treatment.

It is important to follow your healthcare provider’s instructions when taking Filgrastim-Aafi, as the dosage and frequency of administration will vary depending on your individual circumstances. Your healthcare provider will monitor your white blood cell count regularly to ensure that the medication is working effectively.

Like all medications, Filgrastim-Aafi may cause side effects in some patients. Common side effects may include bone pain, headache, and fatigue. If you experience any severe or persistent side effects, it is important to contact your healthcare provider right away.

Overall, Filgrastim-Aafi can be a valuable tool in helping to support the immune system during cancer treatment. If you have any questions or concerns about this medication, be sure to discuss them with your healthcare provider. They can provide you with more information about how Filgrastim-Aafi works and help you determine if it is the right treatment option for you.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN